Rovalpituzumab 是一种针对 delta 样蛋白 3 (DLL3) 的人源化单克隆抗体。Rovalpituzumab 可用于抗体-药物偶联物 (ADC)、Rovalpituzumab Tesirine 的合成。Rovalpituzumab 具有抗小细胞肺癌 (SCLC) 的活性。
货号:ajcx38562
CAS:1613313-01-1
分子式:N/A
分子量：N/A
溶解度:N/A
纯度：98%
存储：Store at -20°C
库存：现货

Background:

Rovalpituzumab is a humanized monoclonal antibody against delta-like protein 3 (DLL3). Rovalpituzumab can be used in the synthesis of antibody-drug conjugate (ADC), Rovalpituzumab Tesirine[1]. Rovalpituzumab has activity against small cell lung cancer (SCLC)[1].

[1]. Bilal H Lashari, et al. Rovalpituzumab Tesirine: A Novel DLL3-Targeting Antibody-Drug Conjugate. Drugs R D. 2018 Dec;18(4):255-258.